Should the dose be increased or should another treatment be considered?
If there has been less than 50% improvement after 6-8 weeks at 10 mg/day divided three times daily, you should modify treatment by either switching to another medication or augmenting the current regimen rather than simply increasing the dose. 1
Assessment Framework
First, evaluate the treatment response since the start date:
- If ≥25% improvement after 4 weeks: Continue current dose and optimize to maximum tolerated dose
- If <25% improvement after 4 weeks: Reassess adherence, drug interactions, and diagnosis; consider changing the medication
- If <50% improvement after 6-8 weeks at optimal dose with good adherence: Modify treatment by switching or augmenting 1
Key Decision Points
Before Making Changes
Conduct a comprehensive review of:
- Medication adherence - Is the patient actually taking the medication as prescribed?
- Drug interactions - Are other medications interfering with efficacy?
- Diagnostic accuracy - Is the diagnosis correct?
- Comorbidities - Are psychiatric or medical comorbidities undermining response?
- Psychosocial stressors - Are external factors preventing improvement? 1
Treatment Modification Options
If inadequate response is confirmed, you have three evidence-based strategies 1:
- Maximize the current dose (if not already at maximum)
- Switch to another medication (within or across pharmacologic classes)
- Augment with another agent (e.g., lithium, thyroid hormone, second-generation antipsychotics, combination antidepressants) or combine with psychotherapy/ECT
Evidence on Dose Escalation
The evidence for dose escalation as a strategy is limited and mixed. Research shows that continuing treatment at the same dose may be as effective as increasing it. In one study of sertraline non-responders, increasing from 100 mg to 200 mg daily actually resulted in a lower response rate (56%) compared to continuing at 100 mg (70%) 2. A systematic review concluded that dose increase is "poorly studied" and "caution is advised in its use" 3.
The most relevant medications for dose escalation appear to be tricyclic antidepressants and serotonin-norepinephrine reuptake inhibitors (SNRIs), but even for these agents, the evidence is not robust 3.
Common Pitfalls
- Premature dose escalation: Many patients show continued improvement between weeks 6-8 without dose changes 2
- Ignoring non-adherence: Increasing dose when the patient isn't taking the medication properly
- Missing comorbidities: Unaddressed anxiety, substance use, or medical conditions can masquerade as treatment resistance
- Inadequate trial duration: Clinical improvement typically requires 4-6 weeks at adequate doses 1
Practical Recommendation
Given that the patient has been on 10 mg/day divided three times daily since [date], calculate the total treatment duration. If this represents 6-8 weeks or more with less than 50% improvement and good adherence, switching or augmentation strategies are preferred over dose escalation based on current evidence 1, 3.